NO20044562L - Fremgangsmater for behandling av tarmslyng - Google Patents

Fremgangsmater for behandling av tarmslyng

Info

Publication number
NO20044562L
NO20044562L NO20044562A NO20044562A NO20044562L NO 20044562 L NO20044562 L NO 20044562L NO 20044562 A NO20044562 A NO 20044562A NO 20044562 A NO20044562 A NO 20044562A NO 20044562 L NO20044562 L NO 20044562L
Authority
NO
Norway
Prior art keywords
methods
bowel disease
treating bowel
treating
patient
Prior art date
Application number
NO20044562A
Other languages
English (en)
Inventor
Leo E Otterbein
Augustine M K Choi
Anthony J Bauer
Beverley A Moore
Original Assignee
Univ Pittsburg Of The Commonwe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburg Of The Commonwe filed Critical Univ Pittsburg Of The Commonwe
Publication of NO20044562L publication Critical patent/NO20044562L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse angår en fremgangsmåte for behandling av tarmslyng hos en pasient, hvilken omfatter å adminisfrere en farmasøytisk sammensetning som omfatter karbonmonoksyd til pasienten.
NO20044562A 2002-04-15 2004-10-22 Fremgangsmater for behandling av tarmslyng NO20044562L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37265202P 2002-04-15 2002-04-15
PCT/US2003/005428 WO2003088923A2 (en) 2002-04-15 2003-02-21 Methods of treating ileus

Publications (1)

Publication Number Publication Date
NO20044562L true NO20044562L (no) 2004-11-15

Family

ID=29250888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044562A NO20044562L (no) 2002-04-15 2004-10-22 Fremgangsmater for behandling av tarmslyng

Country Status (15)

Country Link
US (1) US7687079B2 (no)
EP (1) EP1499333B1 (no)
JP (1) JP4588325B2 (no)
CN (1) CN100496509C (no)
AU (1) AU2003216368B2 (no)
CA (1) CA2481972A1 (no)
EA (1) EA200401365A1 (no)
ES (1) ES2546280T3 (no)
HR (1) HRP20040972A2 (no)
MX (1) MXPA04010243A (no)
NO (1) NO20044562L (no)
PL (1) PL373002A1 (no)
RS (1) RS91004A (no)
UA (1) UA85041C2 (no)
WO (1) WO2003088923A2 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
WO2003000114A2 (en) * 2001-06-21 2003-01-03 Beth Israel Deaconess Medical Center Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
JP2005519928A (ja) * 2002-02-04 2005-07-07 ハース，ベルナー Ｃｏ放出能力を有する化合物の投与によって哺乳動物を治療する方法と、ｃｏ放出能力を有する化合物ならびにその医薬組成物
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
PL374241A1 (en) 2002-04-15 2005-10-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating necrotizing enterocolitis
JP2005522521A (ja) 2002-04-15 2005-07-28 ベス イスラエル デアコネス メディカル センター ヘムオキシゲナーゼ−１およびヘム分解産物の使用法
MXPA04010243A (es) 2002-04-15 2005-07-05 Univ Pittsburgh Metodos para tratar ileo.
DK1505990T3 (da) 2002-05-17 2011-11-21 Univ Yale Fremgangsmåder til behandling af hepatitis
PL374375A1 (en) * 2002-06-05 2005-10-17 Yale University Methods of treating angiogenesis, tumor growth, and metastasis
AU2003279236B8 (en) * 2002-06-21 2009-02-19 Beth Israel Deaconess Medical Center, Inc. Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
MXPA05004924A (es) * 2002-11-07 2005-08-18 Univ Pittsburgh Tratamiento para shock hemorragico.
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
US8893717B2 (en) 2005-09-21 2014-11-25 Ino Therapeutics Llc Systems and methods of administering a pharmaceutical gas to a patient
WO2007073225A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda. Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
LT3210644T (lt) 2009-05-27 2019-02-11 Ino Therapeutics Llc Įrenginiai, skirti sugraduoto vožtuvo ir hermetiško kanistro įrenginio sukabinimui be sandariklio
JP2011010865A (ja) 2009-06-30 2011-01-20 Ikaria Holdings Inc 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
EP3583851A1 (en) 2011-01-14 2019-12-25 Children's Hospital Los Angeles Solution of carbon monoxide for treatment of disease, including sickle cell disease
JP5978291B2 (ja) 2011-04-19 2016-08-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化炭素放出分子およびその使用
EP2734235B1 (en) 2011-07-21 2017-03-22 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
JP2014525399A (ja) 2011-08-09 2014-09-29 ベス・イスラエル・ディーコネス・メディカル・センター，インコーポレイテッド Ｄｎａ損傷を処置する方法
AU2013231976B9 (en) 2012-03-15 2017-12-14 Mallinckrodt Hospital Products IP Limited Methods of administering high concentrations of nitric oxide
TW201618795A (zh) * 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
US20150328073A1 (en) * 2014-05-19 2015-11-19 Joseph Gerard Archer Hyperbaric Social Establishment or Residence
US11771855B2 (en) * 2017-01-10 2023-10-03 Brian Charles Weiner Methods of treating medical conditions with oxygen
JP6618976B2 (ja) * 2017-11-14 2019-12-11 イノ セラピューティクス エルエルシー 指標付弁と襟部を有する加圧容器組立体を係合するため、かつ薬物送達を調整するための装置と流体連通したプランジャ組立体により直線的に作動させるための装置および方法
JP2021525246A (ja) * 2018-05-23 2021-09-24 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 心臓特異的標的化ペプチド（ｃｔｐ）、組成物およびその使用
US11576929B2 (en) 2018-06-08 2023-02-14 Sumitomo Seika Chemicals Co., Ltd. Composition for inflammatory gastrointestinal disorders

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4264739A (en) * 1979-01-05 1981-04-28 Merck & Co., Inc. Sparger for cell culture system
JPS5679957A (en) 1979-12-05 1981-06-30 Sogo Seibutsu Igaku Kenkyusho:Kk Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5449665A (en) * 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
DE3739650C1 (de) * 1987-11-23 1989-05-24 Immuno Ag Fermenter zum Zuechten von Zellkulturen
US5180366A (en) * 1990-10-10 1993-01-19 Woods W T Apparatus and method for angioplasty and for preventing re-stenosis
US5792325A (en) * 1990-11-15 1998-08-11 Richardson, Jr.; William H. Electric arc material processing system
US5293875A (en) * 1992-06-16 1994-03-15 Natus Medical Incorporated In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
ES2219646T5 (es) * 1993-02-22 2008-11-01 Abraxis Bioscience, Inc. Metodos para la administracion in vivo de compuestos biologicos y composiciones utiles para los mismos.
EP0804244A1 (en) 1993-03-26 1997-11-05 Biorelease Technologies, Inc. Compositions including heme-containing proteins and methods relating thereto
US5763431A (en) * 1993-08-20 1998-06-09 Jackson; Meyer B. Method for regulating neuropeptide hormone secretion
DE4421433C1 (de) * 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
US5476764A (en) * 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5664563A (en) * 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5914316A (en) * 1994-12-16 1999-06-22 Washington University Method of inhibiting intimal hyperplasia
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
FR2735382B1 (fr) * 1995-06-15 1997-07-25 Air Liquide Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique
WO1997002036A1 (en) * 1995-06-30 1997-01-23 Zymogenetics, Inc. 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists
PT914103E (pt) * 1996-04-05 2006-09-29 Gen Hospital Corp Tratamento de uma hemoglobinopatia
US6069132A (en) * 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
ATE253372T1 (de) 1996-08-27 2003-11-15 Messer Griesheim Gmbh Wasserstoffhaltiges medikament
US6316403B1 (en) * 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6315995B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
EP0951292B1 (en) * 1996-09-27 2007-04-04 The Trustees of Columbia University in the City of New York Treating an ischemic disorder and improving stroke outcome
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
EP1357120A1 (en) 1998-03-16 2003-10-29 Celgene Corporation 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
US6203991B1 (en) * 1998-08-21 2001-03-20 The Regents Of The University Of Michigan Inhibition of smooth muscle cell migration by heme oxygenase I
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US20050250688A1 (en) * 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
FR2812197B1 (fr) 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
US20040197271A1 (en) * 2001-03-20 2004-10-07 Kunka Robert Leonard Inhalation drug combinations
CN1507348A (zh) * 2001-03-30 2004-06-23 ɣ����ҽҩ��˾ 用于治疗血管性、炎性和免疫疾病的一氧化碳生成性组合物
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
WO2002096387A1 (en) * 2001-05-25 2002-12-05 Medtronic, Inc. Implantable medical device with controllable gaseous agent release system
WO2003000114A2 (en) * 2001-06-21 2003-01-03 Beth Israel Deaconess Medical Center Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
JP2005519928A (ja) * 2002-02-04 2005-07-07 ハース，ベルナー Ｃｏ放出能力を有する化合物の投与によって哺乳動物を治療する方法と、ｃｏ放出能力を有する化合物ならびにその医薬組成物
UA86344C2 (ru) 2002-02-13 2009-04-27 Бет Ізрейел Діконісс Медікал Сентер, Інк. Способ лечения сосудистых заболеваний
JP2005522521A (ja) * 2002-04-15 2005-07-28 ベス イスラエル デアコネス メディカル センター ヘムオキシゲナーゼ−１およびヘム分解産物の使用法
PL374241A1 (en) 2002-04-15 2005-10-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating necrotizing enterocolitis
MXPA04010243A (es) 2002-04-15 2005-07-05 Univ Pittsburgh Metodos para tratar ileo.
EP1501523A4 (en) 2002-05-09 2006-12-13 Univ Yale CARBON MONOXIDE AS A BIOMARKER AND THERAPEUTIC AGENT
DK1505990T3 (da) 2002-05-17 2011-11-21 Univ Yale Fremgangsmåder til behandling af hepatitis
PL374375A1 (en) 2002-06-05 2005-10-17 Yale University Methods of treating angiogenesis, tumor growth, and metastasis
AU2003279236B8 (en) * 2002-06-21 2009-02-19 Beth Israel Deaconess Medical Center, Inc. Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
DE10230165A1 (de) 2002-07-04 2004-01-15 Ino Therapeutics Gmbh Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
MXPA05004924A (es) 2002-11-07 2005-08-18 Univ Pittsburgh Tratamiento para shock hemorragico.

Also Published As

Publication number Publication date
UA85041C2 (ru) 2008-12-25
WO2003088923A2 (en) 2003-10-30
WO2003088923A3 (en) 2004-05-06
EP1499333A2 (en) 2005-01-26
EA200401365A1 (ru) 2005-04-28
AU2003216368A1 (en) 2003-11-03
ES2546280T3 (es) 2015-09-22
CN1658889A (zh) 2005-08-24
CN100496509C (zh) 2009-06-10
US7687079B2 (en) 2010-03-30
MXPA04010243A (es) 2005-07-05
RS91004A (en) 2007-02-05
HRP20040972A2 (en) 2005-06-30
EP1499333B1 (en) 2015-06-24
JP4588325B2 (ja) 2010-12-01
EP1499333A4 (en) 2008-05-28
PL373002A1 (en) 2005-08-08
AU2003216368B2 (en) 2007-08-09
CA2481972A1 (en) 2003-10-30
US20030219497A1 (en) 2003-11-27
JP2005531534A (ja) 2005-10-20

Similar Documents

Publication Publication Date Title
NO20044562L (no) Fremgangsmater for behandling av tarmslyng
NO20045056L (no) Fremgangsmater for behandling av hepatitt
NO20044564L (no) Fremgangsmater for behandling av nekrotiserende enterocolit
NO20052348L (no) Behandling av hemoragisk sjokk
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO20045354L (no) Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
BR0312785A (pt) Tratamento de desordens relacionadas a tnf(alfa)
ATE412636T1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
NO20073830L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
DE60322395D1 (de) Antipruritisches mittel
NO20005223L (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
NO20065196L (no) Terapeutisk kombinasjon for behandling av Alzheimers sykdom
NO20063319L (no) Anvendelse av siramesin i behandlingen av cancer
ATE329907T1 (de) Pyridazinderivate, deren verwendung als heilmittel, und deren verfahren zu ihrer verwendung
RU2004116435A (ru) Способ лечения кровотечений из верхних отделов желудочно-кишечного тракта при ожоговой болезни

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application